Antibacterial activity and pH-dependent loss of efficacy of diffusible naphthoquinone-rich pigments secreted by marine filamentous fungus Fusarium sp. SRD3
Frontiers in Fungal Biology · 04.11.2026 · 7
DOI: 10.3389/ffunb.2026.1963064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Fungal Biology, online erschienen am 04.11.2026. Verfasst von Dalimba Sairoopa und 9 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yenepoya University.
Abstract (Originalsprache)
Naturally occurring fungal metabolites are ideal candidates for combating multidrug-resistant pathogens in clinical settings. However, bacterial susceptibility and conditions affecting the inhibition of bacterial growth remain poorly explored. Here we investigated diffusible naphthoquinone-rich extract (SRD3nQ) originating from a fungal strain SRD3 for antioxidant properties and antibacterial activity toward multiple methicillin-resistant Staphylococcus aureus (MRSA) and drug-resistant Enterococcus faecium , Klebsiella pneumonia , and Acinetobacter baumannii . The sequencing of the D1/D2 region of large subunit (LSU) rRNA gene and associated phylogenetic analysis revealed SRD3 as a strain of Fusarium , which grew well on potato dextrose agar (PDA) in the presence of 0%–10% NaCl, pH 3–10, and at 30°C. SRD3nQ secretion occurred strongly on PDA at pH 3, 0% NaCl, and 6 to12 days of incubation. SRD3nQ exhibited a minimum inhibitory concentration (MIC) of 1.56 μg/mL and fractional inhibitory concentration (FIC) and ∑FIC of 0.125 and 0.61, respectively, in combination with ciprofloxacin, versus Staphylococcus aureus ATCC BAA-44, suggesting a potential additive interaction. Thin-layer chromatography resolved three distinct colored SRD3nQ, designated as lower purple (LP), middle orange (MO), and top purple (TP), with differential antimicrobial and antioxidant activities. The major fraction MO, exhibiting the highest levels of antimicrobial and bactericidal activities, has been putatively annotated as a dimeric naphthoquinone, aurofusarin, through LC–MS/MS analysis, while LP and TP remained unidentified. SRD3nQ retained antibacterial activity following heat treatment, although chemical stability was not directly assessed. SRD3nQ was active against multiple clinical strains of MRSA, particularly under acidic–near-neutral pH. Antibacterial activity was reduced under alkaline conditions, suggesting alkalinity-driven loss of activity. This study provides preliminary evidence that Fusarium sp. SRD3 produces diffusible naphthoquinone metabolites, which are active against drug-resistant pathogens, and further investigation is required to determine the mechanism underlying the pH-dependent activity.
Förderung
- Yenepoya University
Zitieren
APA
Sairoopa, D., Hameed, A., Rahmath, N. A. K., Prarthana, K. P., Veena, B. S., Sarojini, B. K., Najar, M. A., Dwivedi, N., Modi, P. K., & Arun, A. B. (2026). Antibacterial activity and pH-dependent loss of efficacy of diffusible naphthoquinone-rich pigments secreted by marine filamentous fungus Fusarium sp. SRD3. Frontiers in Fungal Biology, 7. https://doi.org/10.3389/ffunb.2026.1963064
Vancouver
Sairoopa D, Hameed A, Rahmath NAK, Prarthana KP, Veena BS, Sarojini BK, et al. Antibacterial activity and pH-dependent loss of efficacy of diffusible naphthoquinone-rich pigments secreted by marine filamentous fungus Fusarium sp. SRD3. Frontiers in Fungal Biology. 2026;7. doi:10.3389/ffunb.2026.1963064
BibTeX
@article{Sairoopa2026,
author = {Sairoopa, Dalimba and Hameed, Asif and Rahmath, Nishmath Abdul Kadar and Prarthana, Karkala Prakash and Veena, Baja Sharada and Sarojini, Balladka Kunhanna and Najar, Mohammad Altaf and Dwivedi, Nidhi and Modi, Prashant Kumar and Arun, Ananthapadmanabha Bhagwath},
title = {Antibacterial activity and pH-dependent loss of efficacy of diffusible naphthoquinone-rich pigments secreted by marine filamentous fungus Fusarium sp. SRD3},
journal = {Frontiers in Fungal Biology},
year = {2026},
volume = {7},
doi = {10.3389/ffunb.2026.1963064}
}
EUVIMED